Solstice, a specialty-materials company listed on Nasdaq under ticker SOLS, declared a quarterly dividend of $0.075 per share on November 3. Shareholders recorded by the close of business on November 25 will receive this dividend payment on December 10. This dividend matches the previous quarterly payout announced in July and paid in September. The consistent dividend reflects Solstice's ongoing commitment to returning value to its shareholders.
Solstice's dividend declaration provides context for readers. For readers following major cryptocurrencies, here is Pluang's market snapshot as of Nov 04, 2026 22:22 WIB: 45 of 50 major cryptocurrencies rose today. THETA rose 5.68% with 96% sell orders, LINK rose 5.32% with 73% buy orders, and AVAX rose 5.26% with 62% buy orders.
The National Advertising Division (NAD) recommended that Good Life Meds discontinue claims about health benefits and personalization for its compounded Tirzepatide+ weight loss products after a challenge by Eli Lilly. NAD found that Good Life lacked ...
Moleculin Biotech announced that interim results from its Phase 2/3 trial of Annamycin for relapsed or refractory acute myeloid leukemia (AML) will be presented at the 2026 ASH Annual Meeting. The trial showed remission rates of 43% and 36% in two An...
The Australia and New Zealand (ANZ) dental implants market, valued at $266 million in 2025, is projected to grow at a 5% CAGR to $393 million by 2033. Growth is driven by increasing demand for oral rehabilitation and prosthetic dentistry, especially ...
Asgard Therapeutics published a study in Immunity demonstrating its technology can reprogram tumor cells into dendritic cells, inducing cancer-fighting tertiary lymphoid structures (imgTLSs) across seven tumor types. This tumor-agnostic approach led ...
Cap, an onchain credit marketplace, is expanding into film and media financing by providing funding for the upcoming film Wake. This deal uses advances against anticipated film production tax credits, showing how Cap's underwriting model supports spe...
